Shanghai Henlius Biotech, Inc. (2696.HK)

HKD 40.35

(3.59%)

Inventory Summary of Shanghai Henlius Biotech, Inc.

Shanghai Henlius Biotech, Inc.'s latest annual inventory in 2023 was 757.35 Million CNY , up 0.01% from previous year.
Shanghai Henlius Biotech, Inc.'s latest quarterly inventory in 2024 Q2 was 783.33 Million CNY , down 0.0% from previous quarter.
Shanghai Henlius Biotech, Inc. reported annual inventory of 757.31 Million CNY in 2022, up 80.26% from previous year.
Shanghai Henlius Biotech, Inc. reported annual inventory of 420.11 Million CNY in 2021, up 37.64% from previous year.
Shanghai Henlius Biotech, Inc. reported quarterly inventory of 783.33 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Shanghai Henlius Biotech, Inc. reported quarterly inventory of 801.98 Million CNY for 2023 Q1, up 5.9% from previous quarter.

Annual Inventory Chart of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Historical Annual Inventory of Shanghai Henlius Biotech, Inc. (2023 - 2017)

Year	Inventory	Inventory Growth
2023	757.35 Million CNY	0.01%
2022	757.31 Million CNY	80.26%
2021	420.11 Million CNY	37.64%
2020	305.22 Million CNY	135.02%
2019	129.87 Million CNY	415.3%
2018	25.2 Million CNY	2.17%
2017	24.66 Million CNY	0.0%

Year	Inventory	Inventory Growth
2024 Q1	783.33 Million CNY	3.43%
2024 Q2	783.33 Million CNY	0.0%
2023 Q1	801.98 Million CNY	5.9%
2023 Q2	801.98 Million CNY	0.0%
2023 Q4	757.35 Million CNY	-1.69%
2023 FY	757.35 Million CNY	0.01%
2023 Q3	770.41 Million CNY	-3.94%
2022 Q2	559.13 Million CNY	0.0%
2022 Q4	757.31 Million CNY	0.0%
2022 Q3	757.31 Million CNY	35.44%
2022 FY	757.31 Million CNY	80.26%
2022 Q1	559.13 Million CNY	33.09%
2021 Q1	346.73 Million CNY	13.6%
2021 FY	420.11 Million CNY	37.64%
2021 Q4	420.11 Million CNY	0.0%
2021 Q3	420.11 Million CNY	21.16%
2021 Q2	346.73 Million CNY	0.0%
2020 Q2	165 Million CNY	0.0%
2020 FY	305.22 Million CNY	135.02%
2020 Q4	305.22 Million CNY	0.0%
2020 Q3	305.22 Million CNY	84.98%
2020 Q1	165 Million CNY	27.05%
2019 FY	129.87 Million CNY	415.3%
2019 Q1	41.86 Million CNY	66.13%
2019 Q4	129.87 Million CNY	0.0%
2019 Q3	129.87 Million CNY	92.71%
2019 Q2	67.39 Million CNY	60.96%
2018 Q3	25.2 Million CNY	0.0%
2018 FY	25.2 Million CNY	2.17%
2018 Q4	25.2 Million CNY	0.0%
2018 Q1	- CNY	0.0%
2017 FY	24.66 Million CNY	0.0%

Peer Inventory Comparison of Shanghai Henlius Biotech, Inc.

Name	Inventory	Inventory Difference
Uni-Bio Science Group Limited	36.39 Million HKD	-1981.114%
CK Life Sciences Int'l., (Holdings) Inc.	1.2 Billion HKD	37.125%